ALIA THERAPEUTICS
Via Visconti Di Modrone Uberto 18 – Milano – 20122
VAT: IT02522690227
nan
Complicit EU Projects
ALIA THERAPEUTICS did not participate in Horizon 2020 (2014-2020).
Within the Horizon Europe (2021-2027) framework, ALIA THERAPEUTICS has received € 259,437.0 for its participation in a total of 1 project(s) with a total cost of € 0.
Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
---|---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 101119927 | IMMERGE | gene therapy · immunology · mutation · personalized medicine · leukemia | 2027-12-31 | participant | € 259,437.6 | € 0 | 3 | 26 | CORDIS ↪ |
ALIA THERAPEUTICS did not participate in FP7 (2007-2013).